← All Sponsors
SPONSOR

Shanghai Pharmaceuticals Holding Co., Ltd

Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2, Phase 1, Phase 2
Conditions studied: Advanced MelanomaAdvanced Solid TumorsHealthy ParticipantsAcute Ischemic Stroke
NCT06214156 Phase 1, Phase 2
Recruiting

A Clinical Study of T3011 in Subjects With Advanced Melanoma

Advanced Melanoma
China View Trial →
NCT05944224 Phase 1, Phase 2
Recruiting

A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

Advanced Solid Tumors
China View Trial →
NCT06839131 Phase 1
Recruiting

A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.

Healthy Participants
China View Trial →
NCT05686642 Phase 2
Recruiting

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Acute Ischemic Stroke
China View Trial →